Le Lézard
Classified in: Health, Business
Subjects: LEG, AVO

Statement of Betsy Ryan, NJHA President and CEO on Trump Administration Ending Insurance Premium Subsidies that Help Low-Income Americans


PRINCETON, N.J., Oct. 13, 2017 /PRNewswire-USNewswire/ -- "We are very disappointed that the Trump Administration is eliminating the subsidies that help people in need buy health insurance. This onslaught of attacks on the Affordable Care Act will have grave impacts on those who count on the ACA for insurance, as well as the entire health insurance market. We call on Congress to step in and swiftly complete work on a repair plan, including reauthorizing the Children's Health Insurance Program. That critical program to protect our kids expired Sept. 30 with no action by our elected officials. This is a very troubling time for U.S. families."

SOURCE New Jersey Hospital Association (NJHA)


These press releases may also interest you

at 05:50
CN Bio Raises $21 Million USD in First Close of Series B Investment Round
CN Bio, a leading provider of single- and multi-organ microphysiological systems, today announced it has raised a $21 million investment in the first close of its Series B fundraising round. The funding has been secured from several new investors;...

at 05:05
Crucial Data Solutions Introduces TrialKit PACS to Streamline Image Management in Clinical Trials
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Physicians and Military Medics In Ukraine Receive Free Point Of Care Ultrasound Training From Global Ultrasound Institute (GUSI)
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir provides update from supportive Type C meeting with the FDA; preparations for enhanced phase 2b in HCC with fostrox + Lenvima continue
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

More news about Health...


News published on and distributed by: